NIOSH Conformity Assessment Letter to Manufacturers, CA 2022-1041-R1 - NIOSH fraud and fraudulent statements policy and new information about using NIOSH marks. This notice and NIOSH CA 2022-1040 supersede NIOSH CA 2022-1041 and NIOSH CA 2021-1032
Public Domain
-
07/19/2022
Details
-
Description:This NIOSH Fraud and Fraudulent Statements Policy was first included in the February 2021 Conformity Assessment Letter to Manufacturers (NIOSH CA 2021-1032). That notice also offered prioritization guidance and is now superseded by this notice – NIOSH CA 2022-1041R1 (fraud and fraudulent statements) – and NIOSH CA 2022-1040 (February 2022 prioritization guidance).
-
Document Type:
-
CIO:
-
Division:
-
NIOSHTIC Number:nn:na
-
Collection(s):
-
Main Document Checksum:urn:sha-512:7021222bd7a4a5db4e8eda311026cbe01ffed76dd36b12dc0b1b05c5b80ddd8f3a5dc95368508af4071bb1a6c72933b1b719426b80502efda4371b47febdd4a7
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like